NL1924R

antibody from Novus Biologicals

Targeting: SOX17

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

NL1924R

Provider

Novus Biologicals

Product name

Goat Polyclonal SOX17 Antibody

Antibody type

Polyclonal

Description

Detects human SOX17 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) SOX2, rhSOX6, and rhSOX15 is observed.

Reactivity

Human

Host

Goat

Isotype

IgG

Vial size

0.5 mL

Storage

Store the unopened product at 2 - 8degrees C. Do not use past expiration date. Protect from light.

References

Submitted references

No evidence of involvement of E-cadherin in cell fate specification or the segregation of Epi and PrE in mouse blastocysts.

Filimonow K, Saiz N, Suwińska A, Wyszomirski T, Grabarek JB, Ferretti E, Piliszek A, Plusa B, Maleszewski M
PloS one 2019;14(2):e0212109

---

Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene.

Domingo-Prim J, Riera M, Abad-Morales V, Ruiz-Nogales S, Corcostegui B, Pomares E
Stem cell research 2019 Oct;40:101570

---

Generation of an induced pluripotent stem cell line (FRIMOi007-A) derived from an incomplete achromatopsia patient carrying a novel homozygous mutation in PDE6C gene.

Domingo-Prim J, Abad-Morales V, Riera M, Navarro R, Corcostegui B, Pomares E
Stem cell research 2019 Oct;40:101569

---

Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.

Riera M, Patel A, Corcostegui B, Chang S, Corneo B, Sparrow JR, Pomares E
Stem cell research 2019 Mar;35:101386

---

Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.

Riera M, Patel A, Corcostegui B, Chang S, Sparrow JR, Pomares E, Corneo B
Stem cell research 2019 Mar;35:101385

---

Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.

Domingo-Prim J, Riera M, Burés-Jelstrup A, Corcostegui B, Pomares E
Stem cell research 2019 Jul;38:101468

---

Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations.

Riera M, Patel A, Burés-Jelstrup A, Corcostegui B, Chang S, Pomares E, Corneo B, Sparrow JR
Stem cell research 2019 Apr;36:101389

---

Nicotinamide Ameliorates Disease Phenotypes in a Human iPSC Model of Age-Related Macular Degeneration.

Saini JS, Corneo B, Miller JD, Kiehl TR, Wang Q, Boles NC, Blenkinsop TA, Stern JH, Temple S
Cell stem cell 2017 May 4;20(5):635-647.e7

---

Oct4 kinetics predict cell lineage patterning in the early mammalian embryo.

Plachta N, Bollenbach T, Pease S, Fraser SE, Pantazis P
Nature cell biology 2011 Feb;13(2):117-23